QQQ   438.60 (+3.05%)
AAPL   184.68 (+1.29%)
MSFT   411.41 (+2.29%)
META   488.97 (+4.47%)
GOOGL   143.65 (+0.77%)
AMZN   174.34 (+3.41%)
TSLA   197.32 (+1.31%)
NVDA   779.75 (+15.57%)
NIO   5.82 (-2.51%)
AMD   182.91 (+11.33%)
BABA   76.13 (+0.73%)
T   16.59 (-2.41%)
F   12.11 (-0.25%)
MU   86.08 (+5.63%)
CGC   3.34 (-2.91%)
GE   151.87 (+1.88%)
DIS   107.80 (+0.12%)
AMC   4.40 (-3.72%)
PFE   27.57 (-0.36%)
PYPL   58.61 (+1.97%)
XOM   104.93 (+0.08%)
QQQ   438.60 (+3.05%)
AAPL   184.68 (+1.29%)
MSFT   411.41 (+2.29%)
META   488.97 (+4.47%)
GOOGL   143.65 (+0.77%)
AMZN   174.34 (+3.41%)
TSLA   197.32 (+1.31%)
NVDA   779.75 (+15.57%)
NIO   5.82 (-2.51%)
AMD   182.91 (+11.33%)
BABA   76.13 (+0.73%)
T   16.59 (-2.41%)
F   12.11 (-0.25%)
MU   86.08 (+5.63%)
CGC   3.34 (-2.91%)
GE   151.87 (+1.88%)
DIS   107.80 (+0.12%)
AMC   4.40 (-3.72%)
PFE   27.57 (-0.36%)
PYPL   58.61 (+1.97%)
XOM   104.93 (+0.08%)
QQQ   438.60 (+3.05%)
AAPL   184.68 (+1.29%)
MSFT   411.41 (+2.29%)
META   488.97 (+4.47%)
GOOGL   143.65 (+0.77%)
AMZN   174.34 (+3.41%)
TSLA   197.32 (+1.31%)
NVDA   779.75 (+15.57%)
NIO   5.82 (-2.51%)
AMD   182.91 (+11.33%)
BABA   76.13 (+0.73%)
T   16.59 (-2.41%)
F   12.11 (-0.25%)
MU   86.08 (+5.63%)
CGC   3.34 (-2.91%)
GE   151.87 (+1.88%)
DIS   107.80 (+0.12%)
AMC   4.40 (-3.72%)
PFE   27.57 (-0.36%)
PYPL   58.61 (+1.97%)
XOM   104.93 (+0.08%)
QQQ   438.60 (+3.05%)
AAPL   184.68 (+1.29%)
MSFT   411.41 (+2.29%)
META   488.97 (+4.47%)
GOOGL   143.65 (+0.77%)
AMZN   174.34 (+3.41%)
TSLA   197.32 (+1.31%)
NVDA   779.75 (+15.57%)
NIO   5.82 (-2.51%)
AMD   182.91 (+11.33%)
BABA   76.13 (+0.73%)
T   16.59 (-2.41%)
F   12.11 (-0.25%)
MU   86.08 (+5.63%)
CGC   3.34 (-2.91%)
GE   151.87 (+1.88%)
DIS   107.80 (+0.12%)
AMC   4.40 (-3.72%)
PFE   27.57 (-0.36%)
PYPL   58.61 (+1.97%)
XOM   104.93 (+0.08%)
NASDAQ:HSKA

Heska (HSKA) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$119.99
$119.99
50-Day Range
$115.55
$119.99
52-Week Range
$57.83
$120.03
Volume
N/A
Average Volume
241,932 shs
Market Capitalization
$1.31 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$133.00

HSKA stock logo

About Heska Stock (NASDAQ:HSKA)

Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado.


HSKA Stock News Headlines

Why Heska (HSKA) Hit a One-Year High Today
Better Than Oil Stocks
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment. 
Why eXp World Holdings Shares Are Rising Thursday
Better Than Oil Stocks
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment. 
Why Heska Stock Is On Fire Today
Heska (HSKA) Moves to Buy: Rationale Behind the Upgrade
Heska (HSKA) Moves 9.0% Higher: Will This Strength Last?
Heska Corporation Reports Third Quarter 2022 Results
See More Headlines
Receive HSKA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Heska and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/04/2021
Today
2/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
NASDAQ:HSKA
Employees
808
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$133.00
High Stock Price Target
$150.00
Low Stock Price Target
$120.00
Potential Upside/Downside
+10.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$-19,890,000.00
Pretax Margin
-7.91%

Debt

Sales & Book Value

Annual Sales
$257.31 million
Cash Flow
$1.69 per share
Book Value
$39.00 per share

Miscellaneous

Free Float
9,572,000
Market Cap
$1.31 billion
Optionable
Not Optionable
Beta
1.58
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Kevin S. WilsonMr. Kevin S. Wilson (Age 51)
    CEO, Pres & Director
    Comp: $988.17k
  • Ms. Catherine I. Grassman CPAMs. Catherine I. Grassman CPA (Age 47)
    Exec. VP & CFO
    Comp: $536.46k
  • Mr. Christopher D. Sveen (Age 40)
    EVP, Chief Admn. Officer, Gen. Counsel, Corp. Sec. & Pres of Diamond Animal Health
    Comp: $457.89k
  • Mr. Steven M. Eyl (Age 57)
    Exec. VP, Chief Commercial Officer & Pres of scil animal care company
    Comp: $475.28k
  • Ms. Eleanor F. Baker (Age 38)
    Exec. VP, MD & COO of Scil Animal Care Company
    Comp: $467.77k
  • Mr. Jon Aagaard
    Director of Investor Relations
  • Mr. Anthony C. Providenti Jr. (Age 56)
    Exec. VP of Corp. Devel.
  • Dr. Nancy Wisnewski Ph.D. (Age 60)
    Chief Science Advisor to CEO
  • Daniel J. Pollack
    VP of Imaging Operations, Treasurer & Assistant Sec.
  • Cynthia Patterson
    VP of Customer Care














HSKA Stock Analysis - Frequently Asked Questions

Should I buy or sell Heska stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Heska in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" HSKA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HSKA, but not buy additional shares or sell existing shares.
View HSKA analyst ratings
or view top-rated stocks.

What is Heska's stock price target for 2024?

2 brokers have issued twelve-month price objectives for Heska's stock. Their HSKA share price targets range from $120.00 to $150.00. On average, they predict the company's share price to reach $133.00 in the next year. This suggests a possible upside of 10.8% from the stock's current price.
View analysts price targets for HSKA
or view top-rated stocks among Wall Street analysts.

How were Heska's earnings last quarter?

Heska Co. (NASDAQ:HSKA) posted its quarterly earnings data on Thursday, November, 4th. The medical research company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of $0.04 by $0.23. The medical research company had revenue of $60.24 million for the quarter, compared to analysts' expectations of $63.80 million. Heska had a negative net margin of 7.86% and a positive trailing twelve-month return on equity of 0.94%. Heska's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.25) earnings per share.

What is Kevin S. Wilson's approval rating as Heska's CEO?

5 employees have rated Heska Chief Executive Officer Kevin S. Wilson on Glassdoor.com. Kevin S. Wilson has an approval rating of 57% among the company's employees. This puts Kevin S. Wilson in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Heska own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Heska investors own include Gilead Sciences (GILD), Exxon Mobil (XOM), Netflix (NFLX), Biogen (BIIB), AbbVie (ABBV), Amgen (AMGN), Broadcom (AVGO), Alibaba Group (BABA), Exelixis (EXEL) and Merck & Co., Inc. (MRK).

This page (NASDAQ:HSKA) was last updated on 2/22/2024 by MarketBeat.com Staff